普瑞眼科
(301239)
| 流通市值：34.85亿 | | | 总市值：73.66亿 |
| 流通股本：7078.95万 | | | 总股本：1.50亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 675,882,973.16 | 2,717,873,370.9 | 2,166,125,568.45 | 1,377,971,782.3 |
| 营业收入 | 675,882,973.16 | 2,717,873,370.9 | 2,166,125,568.45 | 1,377,971,782.3 |
| 二、营业总成本 | 636,079,700.34 | 2,417,543,217.55 | 1,846,235,666.59 | 1,169,426,604.49 |
| 营业成本 | 401,898,789.1 | 1,522,034,985.73 | 1,179,555,373.73 | 752,656,658.3 |
| 税金及附加 | 1,261,475.64 | 6,425,121.78 | 4,154,059.33 | 2,172,950.62 |
| 销售费用 | 110,660,221.97 | 448,608,343.37 | 346,451,019.62 | 217,290,674.51 |
| 管理费用 | 101,727,180.35 | 364,779,038.68 | 262,937,736.3 | 163,856,623.06 |
| 研发费用 | 2,410,662.58 | 11,033,602.57 | 7,155,122.27 | 4,865,185.43 |
| 财务费用 | 18,121,370.7 | 64,662,125.42 | 45,982,355.34 | 28,584,512.57 |
| 其中:利息费用 | 20,618,729.82 | 74,668,237.7 | 54,327,555.72 | 33,882,354.37 |
| 其中:利息收入 | 4,134,359.65 | 17,161,759.32 | - | 8,586,948.93 |
| 加:公允价值变动收益 | - | 101,593.07 | - | - |
| 加:投资收益 | 583,182.02 | 78,187,114.17 | 92,579,390.96 | 92,783,294.14 |
| 资产处置收益 | -16,527.54 | 57,736.49 | 40,085.4 | 6,002.6 |
| 资产减值损失(新) | -100,594.1 | -1,775,055.82 | -1,287,662.38 | -785,911.77 |
| 信用减值损失(新) | -629,680.23 | -5,004,719.43 | -4,491,832.02 | -3,596,977.53 |
| 其他收益 | 1,715,944.42 | 14,111,686.69 | 12,360,128.11 | 6,398,330.73 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 41,355,597.39 | 386,008,508.52 | 419,090,011.93 | 303,349,915.98 |
| 加:营业外收入 | 82,910.59 | 867,019.05 | 329,291.13 | 241,245.88 |
| 减:营业外支出 | 4,460,961.6 | 24,641,898.97 | 15,247,872.91 | 10,736,204.95 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 36,977,546.38 | 362,233,628.6 | 404,171,430.15 | 292,854,956.91 |
| 减:所得税费用 | 17,934,906.28 | 84,228,022.99 | 78,428,960.14 | 52,478,067.05 |
| 六、净利润 | 19,042,640.1 | 278,005,605.61 | 325,742,470.01 | 240,376,889.86 |
| 持续经营净利润 | 19,042,640.1 | 278,005,605.61 | 325,742,470.01 | 240,376,889.86 |
| 归属于母公司股东的净利润 | 16,924,936.43 | 267,913,456.76 | 317,242,547.43 | 234,826,276.55 |
| 少数股东损益 | 2,117,703.67 | 10,092,148.85 | 8,499,922.58 | 5,550,613.31 |
| (一)基本每股收益 | 0.11 | 1.79 | 2.12 | 1.57 |
| (二)稀释每股收益 | 0.11 | 1.79 | 2.12 | 1.57 |
| 八、其他综合收益 | - | -1,134.78 | - | - |
| 归属于母公司股东的其他综合收益 | - | -1,134.78 | - | - |
| 九、综合收益总额 | 19,042,640.1 | 278,004,470.83 | 325,742,470.01 | 240,376,889.86 |
| 归属于母公司股东的综合收益总额 | 16,924,936.43 | 267,912,321.98 | 317,242,547.43 | 234,826,276.55 |
| 归属于少数股东的综合收益总额 | 2,117,703.67 | 10,092,148.85 | 8,499,922.58 | 5,550,613.31 |
| 公告日期 | 2024-04-24 | 2024-04-24 | 2023-10-30 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |